Mid-Gestational Gene Expression Profile in Placenta and Link to Pregnancy Complications

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Uusküla, Liis ^a   Männik, Jaana ^a,b   Rull, Kristiina ^a,c   Minajeva, Ave ^c   Kõks, Sulev ^a   Vaas, Pille ^c   Teesalu, Pille ^c   Reimand, Jüri ^d   Laan, Maris ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF TENNESSEE   (United States)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; TRANSCRIPTOME;

ADULT; ARTICLE; BMP5 GENE; CCNG2 GENE; CDH11 GENE; CONTROLLED STUDY; FEMALE; FST GENE; GATM GENE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GESTATIONAL AGE; GPR138 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ITGBL1 GENE; LARGE GESTATIONAL AGE; LYPD6 GENE; MAJOR CLINICAL STUDY; MALE; MATERNAL PLASMA; MEG3 GENE; MID GESTATIONAL AGE; NEDD9 GENE; NEWBORN; NR3C1 GENE; NRCAM GENE; NUCLEOTIDE SEQUENCE; PLACENTA; PLAGL1 GENE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PUERPERIUM; QUALITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SLC16A10 GENE; SMALL GESTATIONAL AGE; STC1 GENE; THIRD TRIMESTER PREGNANCY; TRANSCRIPTION REGULATION; ZFP36L1 GENE;

ADOLESCENT; ADULT; ANTIGENS, LY; CYCLIN G2; DIABETES, GESTATIONAL; FEMALE; FETAL DEVELOPMENT; FETAL GROWTH RETARDATION; GENE EXPRESSION PROFILING; GENETIC MARKERS; GLYCOPROTEINS; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; TRANSCRIPTOME;

EID: 84868695441     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049248     Document Type: Article

References (73)

1. Cross JC, (2006) Placental function in development and disease. Reprod Fertil Dev 18: 71-76.
2. Kim SJ, Lee SY, Lee C, Kim I, An HJ, et al. (2006) Differential expression profiling of genes in a complete hydatidiform mole using cDNA microarray analysis. Gynecol Oncol 103: 654-660.
3. Enquobahrie DA, Williams MA, Qiu C, Meller M, Sorensen TK (2009) Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol 200: 206 e201-213.
4. Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658.
5. Nevo O, Many A, Xu J, Kingdom J, Piccoli E, et al. (2008) Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 93: 285-292.
6. Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, et al. (2011) Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 9: 107.
7. Sagawa N, Yura S, Itoh H, Kakui K, Takemura M, et al. (2002) Possible role of placental leptin in pregnancy: a review. Endocrine 19: 65-71.
8. Struwe E, Berzl G, Schild R, Blessing H, Drexel L, et al. (2010) Microarray analysis of placental tissue in intrauterine growth restriction. Clin Endocrinol (Oxf) 72: 241-247.
9. Novakovic B, Yuen RK, Gordon L, Penaherrera MS, Sharkey A, et al. (2011) Evidence for widespread changes in promoter methylation profile in human placenta in response to increasing gestational age and environmental/stochastic factors. BMC Genomics 12: 529.
10. Sitras V, Fenton C, Paulssen R, Vartun A, Acharya G, (2012) Differences in Gene Expression between First and Third Trimester Human Placenta: A Microarray Study. PLoS One 7: e33294.
11. Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, et al. (2007) Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology 148: 1059-1079.
12. Mikheev AM, Nabekura T, Kaddoumi A, Bammler TK, Govindarajan R, et al. (2008) Profiling gene expression in human placentae of different gestational ages: an OPRU Network and UW SCOR Study. Reprod Sci 15: 866-877.
13. Karro H, Rahu M, Gornoi K, Baburin A, (1997) Sünnikaalu jaotumine raseduse kestuse järgi Eestis aastail 1992-1994. Eesti Arst 4: 299-303.
14. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
15. Li C, Wong WH, (2001) Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A 98: 31-36.
16. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing. J Royal Stat Soc 57: 289-300.
17. Reimand J, Arak T, Vilo J, (2011) g:Profiler-a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res 39: W307-315.
18. Miyoshi N, Wagatsuma H, Wakana S, Shiroishi T, Nomura M, et al. (2000) Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. Genes Cells 5: 211-220.
19. Sandell LL, Guan XJ, Ingram R, Tilghman SM, (2003) Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta. Proc Natl Acad Sci U S A 100: 4622-4627.
20. Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, et al. (2006) Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell 11: 711-722.
21. Muller PY, Janovjak H, Miserez AR, Dobbie Z (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1374, 1376, 1378-1379.
22. Zhang X, Rice K, Wang Y, Chen W, Zhong Y,et al. Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 151: 939-947.
23. Yeung BH, Law AY, Wong CK, (2012) Evolution and roles of stanniocalcin. Mol Cell Endocrinol 349: 272-280.
24. Zhang Y, Lang Q, Li J, Xie F, Wan B, et al. (2010) Identification and characterization of human LYPD6, a new member of the Ly-6 superfamily. Mol Biol Rep 37: 2055-2062.
25. Deol HK, Varghese R, Wagner GF, Dimattia GE, (2000) Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation. Endocrinology 141: 3412-3421.
26. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, et al. (2010) Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 28: 1248-1250.
27. Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, et al. (2000) Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J 350 Pt 2: 453-461.
28. Huppertz B, (2011) Placental pathology in pregnancy complications. Thromb Res 127 (Suppl 3):: S96-99.
29. Ornoy A, (2011) Prenatal origin of obesity and their complications: Gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia. Reprod Toxicol 32: 205-212.
30. Bennin DA, Don AS, Brake T, McKenzie JL, Rosenbaum H, et al. (2002) Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem 277: 27449-27467.
31. Khan MA, Mittal S, Kumar S, Sengupta J, Ghosh D, (2010) Quantitative analysis of six gene products as candidate markers of early placental villi development in the human. Indian J Physiol Pharmacol 54: 299-308.
32. Meller M, Vadachkoria S, Luthy DA, Williams MA, (2005) Evaluation of housekeeping genes in placental comparative expression studies. Placenta 26: 601-607.
33. Rull K, Hallast P, Uuskula L, Jackson J, Punab M, et al. (2008) Fine-scale quantification of HCG beta gene transcription in human trophoblastic and non-malignant non-trophoblastic tissues. Mol Hum Reprod 14: 23-31.
34. Allegra A, Marino A, Coffaro F, Lama A, Rizza G, et al. (2009) Is there a uniform basal endometrial gene expression profile during the implantation window in women who became pregnant in a subsequent ICSI cycle? Hum Reprod 24: 2549-2557.
35. Song G, Dunlap KA, Kim J, Bailey DW, Spencer TE, et al. (2009) Stanniocalcin 1 is a luminal epithelial marker for implantation in pigs regulated by progesterone and estradiol. Endocrinology 150: 936-945.
36. Song G, Bazer FW, Wagner GF, Spencer TE, (2006) Stanniocalcin (STC) in the endometrial glands of the ovine uterus: regulation by progesterone and placental hormones. Biol Reprod 74: 913-922.
37. Yue L, Daikoku T, Hou X, Li M, Wang H, et al. (2005) Cyclin G1 and cyclin G2 are expressed in the periimplantation mouse uterus in a cell-specific and progesterone-dependent manner: evidence for aberrant regulation with Hoxa-10 deficiency. Endocrinology 146: 2424-2433.
38. Kokkinos MI, Murthi P, Wafai R, Thompson EW, Newgreen DF, (2010) Cadherins in the human placenta-epithelial-mesenchymal transition (EMT) and placental development. Placenta 31: 747-755.
39. Stumpo DJ, Byrd NA, Phillips RS, Ghosh S, Maronpot RR, et al. (2004) Chorioallantoic fusion defects and embryonic lethality resulting from disruption of Zfp36L1, a gene encoding a CCCH tandem zinc finger protein of the Tristetraprolin family. Mol Cell Biol 24: 6445-6455.
40. Guenther C, Pantalena-Filho L, Kingsley DM, (2008) Shaping skeletal growth by modular regulatory elements in the Bmp5 gene. PLoS Genet 4: e1000308.
41. Farber CR, Kelly SA, Baruch E, Yu D, Hua K, et al. (2011) Identification of quantitative trait loci influencing skeletal architecture in mice: emergence of Cdh11 as a primary candidate gene regulating femoral morphology. J Bone Miner Res 26: 2174-2183.
42. Gajos-Michniewicz A, Piastowska AW, Russell JA, Ochedalski T, (2010) Follistatin as a potent regulator of bone metabolism. Biomarkers 15: 563-574.
43. Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, et al. (2010) Regulation of muscle mass by follistatin and activins. Mol Endocrinol 24: 1998-2008.
44. Braissant O, Henry H, Villard AM, Speer O, Wallimann T, et al. (2005) Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev Biol 5: 9.
45. Valente T, Junyent F, Auladell C, (2005) Zac1 is expressed in progenitor/stem cells of the neuroectoderm and mesoderm during embryogenesis: differential phenotype of the Zac1-expressing cells during development. Dev Dyn 233: 667-679.
46. Yuasa S, Onizuka T, Shimoji K, Ohno Y, Kageyama T, et al. (2010) Zac1 is an essential transcription factor for cardiac morphogenesis. Circ Res 106: 1083-1091.
47. Du X, Rousseau M, Ounissi-Benkalha H, Marchand L, Jetha A, et al. (2011) Differential expression pattern of ZAC in developing mouse and human pancreas. J Mol Histol 42: 129-136.
48. Zhou Y, Cheunsuchon P, Nakayama Y, Lawlor MW, Zhong Y, et al. (2010) Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene. Development 137: 2643-2652.
49. Azzi S, Rossignol S, Steunou V, Sas T, Thibaud N, et al. (2009) Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci. Hum Mol Genet 18: 4724-4733.
50. Johnston J, Ramos-Valdes Y, Stanton LA, Ladhani S, Beier F, et al. (2010) Human stanniocalcin-1 or-2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth. Transgenic Res 19: 1017-1039.
51. Böger CA, Gorski M, Li M, Hoffmann MM, Huang C, et al. (2011) Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD. PLoS Genet 7: e1002292.
52. Köttgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, et al. (2009) Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41: 712-717.
53. Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, et al. (2010) Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst 102: 812-827.
54. Law AY, Ching LY, Lai KP, Wong CK, (2010) Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1 gene. Mol Cell Endocrinol 314: 118-127.
55. Yeung HY, Lai KP, Chan HY, Mak NK, Wagner GF, et al. (2005) Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 146: 4951-4960.
56. Marzioni D, Todros T, Cardaropoli S, Rolfo A, Lorenzi T, et al. (2010) Activating protein-1 family of transcription factors in the human placenta complicated by preeclampsia with and without fetal growth restriction. Placenta 31: 919-927.
57. Bamberger AM, Bamberger CM, Aupers S, Milde-Langosch K, Loning T, et al. (2004) Expression pattern of the activating protein-1 family of transcription factors in the human placenta. Mol Hum Reprod 10: 223-228.
58. Bates S, Rowan S, Vousden KH, (1996) Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene 13: 1103-1109.
59. Bonnin A, Goeden N, Chen K, Wilson ML, King J, et al. (2011) A transient placental source of serotonin for the fetal forebrain. Nature 472: 347-350.
60. Barker DJ, Eriksson JG, Forsen T, Osmond C, (2002) Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31: 1235-1239.
61. Bramlage CP, Haupl T, Kaps C, Ungethum U, Krenn V, et al. (2006) Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 8: R58.
62. Karlsson C, Dehne T, Lindahl A, Brittberg M, Pruss A, et al. (2010) Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 18: 581-592.
63. Tardif G, Hum D, Pelletier JP, Boileau C, Ranger P, et al. (2004) Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 50: 2521-2530.
64. Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, et al. (2006) Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation 114: I16-20.
65. Sheikh-Hamad D, Bick R, Wu GY, Christensen BM, Razeghi P, et al. (2003) Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure. Am J Physiol Heart Circ Physiol 285: H442-448.
66. Wallace C, Smyth DJ, Maisuria-Armer M, Walker NM, Todd JA, et al. (2010) The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet 42: 68-71.
67. Heinig M, Petretto E, Wallace C, Bottolo L, Rotival M, et al. (2010) A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 467: 460-464.
68. Kino T, Charmandari E, Chrousos GP, (2011) Glucocorticoid receptor: implications for rheumatic diseases. Clin Exp Rheumatol 29: S32-41.
69. Marui T, Funatogawa I, Koishi S, Yamamoto K, Matsumoto H, et al. (2009) Association of the neuronal cell adhesion molecule (NRCAM) gene variants with autism. Int J Neuropsychopharmacol 12: 1-10.
70. Chapuis J, Moisan F, Mellick G, Elbaz A, Silburn P, et al. (2008) Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease. Hum Mol Genet 17: 2863-2867.
71. Li Y, Grupe A, Rowland C, Holmans P, Segurado R, et al. (2008) Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. Hum Mol Genet 17: 759-767.
72. Chung BH, Mullegama S, Marshall CR, Lionel AC, Weksberg R, et al. (2012) Severe intellectual disability and autistic features associated with microduplication 2q23.1. Eur J Hum Genet 20: 398-403.
73. McKay R, (2011) Developmental biology: Remarkable role for the placenta. Nature 472: 298-299.